13F-HR filed by Athyrium Capital Management, LP
Athyrium Capital Management, LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 6 holding rows worth $280,491,000.
- Accession
- 0001567619-22-004383
- Filer
- CIK 1728001
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 6 entries on the cover page, a total value of $280,491,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $280,491,000 with VALUE read as thousands by filing date, 13F file number 028-18509. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 8,857,268 | $95,658,000 | thousands by filing date | |
| BIORA THERAPEUTICS INC | 74319FAB3 | NOTE 7.250%12/0 | 103,500,000 | $75,405,000 | thousands by filing date | principal |
| BIORA THERAPEUTICS INC | 74319F107 | COM | 29,855,847 | $62,399,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 4,487,220 | $34,462,000 | thousands by filing date | |
| RVL PHARMACEUTICALS PLC | G6S41R101 | COM | 8,148,832 | $8,801,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 2,202,420 | $3,766,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-004383 | this filing | 2022-02-14 | acceptance time not in the bulk data set |